drugset / Trial / NCT05605639

Phrenic Nerve Infiltration in Neck Pain

NCT05605639 ↗

Phase 4 Recruiting 60 enrolled University of Seville
RandomizedParallel-groupTriple-blindTreatment

Summary

Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve. It is known that peridiaphragmatic organs trigger referred pain in the neck area. As well, previous studies have shown that visceral disorders increase sensitization in somatic tissues. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization and improve neck symptoms in the absence of neurological, traumatic or infectious pathology that justifies the pain, by means of a randomized controlled trial.

Timeline

Start
2022-11-17
Primary completion
2025-07
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 3 ml Other

Indications